These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10083529

  • 1. Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model.
    Schorlemmer HU, Bartlett RR, Lindner JK, Kurrle R.
    Transplant Proc; 1999; 31(1-2):1184-8. PubMed ID: 10083529
    [No Abstract] [Full Text] [Related]

  • 2. Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus.
    Schorlemmer HU, Bartlett RR, Lindner JK, Kurrle R.
    Transplant Proc; 1998 Dec; 30(8):4099-103. PubMed ID: 9865312
    [No Abstract] [Full Text] [Related]

  • 3. Combination therapy of malononitrilamides and tacrolimus (FK 506) induced long-term xenograft survival.
    Schorlemmer HU, Kurrle R.
    Transplant Proc; 1998 Dec; 30(8):4170-3. PubMed ID: 9865337
    [No Abstract] [Full Text] [Related]

  • 4. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU, Schwab W, Ruuth E, Kurrle R.
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract] [Full Text] [Related]

  • 5. Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model.
    Schorlemmer HU, Bartlett RR, Kurrle R.
    Transplant Proc; 1999 Dec; 31(1-2):851-3. PubMed ID: 10083371
    [No Abstract] [Full Text] [Related]

  • 6. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU, Kurrle R.
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract] [Full Text] [Related]

  • 7. Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
    Schorlemmer HU, Kurrle R.
    Transplant Proc; 1998 Jun; 30(4):976-9. PubMed ID: 9636394
    [No Abstract] [Full Text] [Related]

  • 8. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU, Kurrle R.
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK, Ouyang J, Wang X, Zhu S, Jiang W, Qi S, Xu D, Hebert MJ, Bekersky I, Fitzsimmons WE, Chen H.
    Transplantation; 2003 Jun 15; 75(11):1881-7. PubMed ID: 12811249
    [Abstract] [Full Text] [Related]

  • 10. Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine.
    Schorlemmer HU, Kurrle R.
    Transplant Proc; 1997 Dec 15; 29(8):3501-4. PubMed ID: 9414811
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M, Antoniou E, DeRoover A, Nishimura Y, Howie A, McMaster P.
    Transplant Proc; 1996 Apr 15; 28(2):930-1. PubMed ID: 8623467
    [No Abstract] [Full Text] [Related]

  • 12. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M, Antoniou E, DeRoover A, Nishimura Y, Howie A, McMaster P.
    Transplant Proc; 1996 Apr 15; 28(2):950-1. PubMed ID: 8623476
    [No Abstract] [Full Text] [Related]

  • 13. Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis.
    Schorlemmer HU, Kurrle R, Schleyerbach R, Bartlett RR.
    Inflamm Res; 1999 Dec 15; 48 Suppl 2():S113-4. PubMed ID: 10667840
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
    Schorlemmer HU, Seiler FR, Bartlett RR.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):763-7. PubMed ID: 8438472
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunomodulatory activity of malononitrilamides, derivatives of leflunomide's primary metabolite, on models of experimental rheumatoid arthritis.
    Schorlemmer HU, Bartlett RR, Schleyerbach R.
    Transplant Proc; 1998 Dec 15; 30(8):4137-9. PubMed ID: 9865326
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.